AUP.TO - Aurinia Pharmaceutic...

Discounted Cash Flow Model Levered of Aurinia Pharmaceuticals Inc.(AUP.TO), Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercialize

Aurinia Pharmaceuticals Inc.

AUP.TO

TSX

Inactive Equity

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.

16.76 CAD

-0.6100006 (-3.64%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.